These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 4598802)

  • 61. [Various aspects of immunopathogenesis of multiple sclerosis and therapeutic possibilities].
    Aleksandrowicz J; Blicharski J; Skotnicki A; Retinger M; Zduńczyk A
    Pol Tyg Lek; 1981 Aug; 36(35):1363-5. PubMed ID: 7036112
    [No Abstract]   [Full Text] [Related]  

  • 62. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
    Stuerzebecher S; Martin R
    Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Polypharmacy in multiple sclerosis.
    Myers LW; Phillips JT
    Epilepsy Res Suppl; 1996; 11():181-95. PubMed ID: 9294736
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The aetiology and pathogenesis of multiple sclerosis.
    Adams CW; Hallpike JF
    Guys Hosp Rep; 1969; 118(2):263-86. PubMed ID: 4896181
    [No Abstract]   [Full Text] [Related]  

  • 65. More immunosuppressives needed.
    Nature; 1969 Mar; 221(5183):805-6. PubMed ID: 5765049
    [No Abstract]   [Full Text] [Related]  

  • 66. [On the viral etiology of multiple sclerosis and encephalomyelitis].
    Zinchenko AP
    Vopr Psikhiatr Nevropatol; 1966; 12():90-9. PubMed ID: 5991559
    [No Abstract]   [Full Text] [Related]  

  • 67. The limitations of immunosuppressant therapy in Multiple Sclerosis.
    Sedal L
    J Clin Neurosci; 2000 Nov; 7(6):563-4; discussion 564-5. PubMed ID: 11029245
    [No Abstract]   [Full Text] [Related]  

  • 68. [Experiences with immunosuppressive treatment of multiple sclerosis].
    Wieczorek V; Lehnert W; Brodkorb W
    Dtsch Gesundheitsw; 1971 Sep; 26(38):1791-4. PubMed ID: 5142348
    [No Abstract]   [Full Text] [Related]  

  • 69. Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome.
    Kimiskidis V; Sakellari I; Tsimourtou V; Kapina V; Papagiannopoulos S; Kazis D; Vlaikidis N; Anagnostopoulos A; Fassas A
    Mult Scler; 2008 Mar; 14(2):278-83. PubMed ID: 17942513
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Therapeutic problems in disseminated encephalomyelitis (multiple sclerosis)].
    Payk TR
    Ther Ggw; 1973 Mar; 112(3):349-50. PubMed ID: 4573496
    [No Abstract]   [Full Text] [Related]  

  • 71. [Multiple sclerosis. 3. Gliotoxic factors].
    Berg O; Källén B
    Lakartidningen; 1970 Jul; 67(29):3292-6. PubMed ID: 4916239
    [No Abstract]   [Full Text] [Related]  

  • 72. Skin-fixing antibodies and neurological disorders.
    Ansari KA
    Trans Am Neurol Assoc; 1970; 95():198-200. PubMed ID: 5514367
    [No Abstract]   [Full Text] [Related]  

  • 73. [Therapy of multiple sclerosis].
    Bereznai B; Goebels N; Dang T; Voltz R; Walther E; Zimmermann C; Hohlfeld R
    Dtsch Med Wochenschr; 1999 May; 124(19):595-9. PubMed ID: 10365178
    [No Abstract]   [Full Text] [Related]  

  • 74. [Immunosuppressive therapy].
    Schumacher K; Gross R
    Internist (Berl); 1984 Jan; 25(1):51-9. PubMed ID: 6370894
    [No Abstract]   [Full Text] [Related]  

  • 75. [Therapeutic strategies for multiple sclerosis--update 2008].
    Kanter vI; Mäurer M
    MMW Fortschr Med; 2008 Jun; 150(23):42-5. PubMed ID: 18575371
    [No Abstract]   [Full Text] [Related]  

  • 76. [Human herpesvirus 6 and multiple sclerosis].
    Piédrola Angulo G
    An R Acad Nac Med (Madr); 2005; 122(2):377-89; discussion 389-92. PubMed ID: 16463579
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Immunosuppressive agents].
    Mertens HG
    Med Welt; 1980 Oct; 31(40):1440-3. PubMed ID: 7464499
    [No Abstract]   [Full Text] [Related]  

  • 78. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease.
    Weiner HL
    Arch Neurol; 2004 Oct; 61(10):1613-5. PubMed ID: 15477521
    [No Abstract]   [Full Text] [Related]  

  • 79. [Treatment of autoimmune diseases].
    Wasastjerna C
    Duodecim; 1973; 89(2):218-26. PubMed ID: 4685136
    [No Abstract]   [Full Text] [Related]  

  • 80. [Gliotoxic properties of multiple sclerosis and polyradiculoneuritis serum detectable in brain organ culture].
    Smirnov IuK; Ravkina LI; Goriunova AG; Veĭn AM; Khomak VIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):181-3. PubMed ID: 7041493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.